SONX Stock Overview
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada.
Sonendo, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$2.38|
|52 Week High||US$11.84|
|52 Week Low||US$0.86|
|1 Month Change||32.22%|
|3 Month Change||100.00%|
|1 Year Change||-75.46%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-74.13%|
Recent News & Updates
|SONX||US Medical Equipment||US Market|
Return vs Industry: SONX underperformed the US Medical Equipment industry which returned -21.7% over the past year.
Return vs Market: SONX underperformed the US Market which returned -20.5% over the past year.
|SONX Average Weekly Movement||24.0%|
|Medical Equipment Industry Average Movement||8.7%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: SONX is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 24% a week.
Volatility Over Time: SONX's weekly volatility has increased from 19% to 24% over the past year.
About the Company
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment device for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of EDTA that is used to help debride and disinfect the root canal system.
Sonendo, Inc. Fundamentals Summary
|SONX fundamental statistics|
Is SONX overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SONX income statement (TTM)|
|Cost of Revenue||US$29.72m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-1.20|
|Net Profit Margin||-152.37%|
How did SONX perform over the long term?See historical performance and comparison